PROTEOLUTIONS

Live / Allowed — Published for opposition (as of 21 Jul 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Jun 2025 filing date already counts against anyone who files later.

Record

Serial number
79433858
Mark type
Stylized text
Filed
11 Jun 2025
Published for opposition
21 Jul 2026
Attorney of record
Ralph Locher

Goods and services

  • Class 001 — Chemicals: Biological preparations for use in industry and science; nucleic recombinant acids, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for protein expression, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for universal protein expression in a variety of production organisms, other than for medical use or veterinary purposes; Protein in raw material form for scientific and medical research and protein for industrial use, namely, recombinant proteins, protein sequences, for use in industry, science, in particular, in silico designed binding proteins; Nucleic acids, other than for medical or veterinary purposes, namely, nucleic acid sequencing programs.
  • Class 005 — Pharmaceuticals: Medical and veterinary preparations, namely, biological and biochemical reagents for medical or veterinary purposes, and diagnostic agents, preparations and substances for medical and veterinary purposes; nucleic recombinant acids and nucleic recombinant sequences, for medical use; biological and biochemical reagents for medical or veterinary purposes, namely, recombinant proteins and protein sequences, for medical use, especially, in silico designed protein agents; biological and biochemical reagents for medical or veterinary purposes, namely, codon-optimized DNA sequences for protein expression, for medical use.
  • Class 009 — Scientific and electric apparatus: Recorded content, namely, recorded computer programs for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents, and electronic data files and databases recorded on computer media in the field of codon optimized DNA sequences for protein expression; downloadable software, including downloadable application software, system and system support software and firmware, web applications and server software, artificial intelligence software and machine learning software for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents; computer interfaces and recorded application programming interface (API) software for the automated codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents
  • Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis and product development in the field of codon-optimized DNA sequences for protein expression, binding proteins and protein-based agents, providing codon-optimized DNA sequence technology research information for protein expression and product research and design relating thereto; DNA screening and optimization for scientific research purposes, all of the above for use in industry, especially, the creation of codon-optimized DNA sequences for protein expression and the creation of codon-optimized DNA sequences for universal protein expression in a variety of production organisms; computer aided design services, in relation to binding proteins, protein-based agents; consultancy and information in relation to the aforesaid services, included in this class.

Owner

Prosecution history

  • 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
  • 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 Jul 2026 — PUBLISHED FOR OPPOSITION
  • 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 25 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 24 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
  • 24 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
  • 24 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
  • 01 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 01 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 01 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 01 Jan 2026 — REFUSAL PROCESSED BY IB
  • 17 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

View this trademark record on Marksy